The key finding
This 2025 review examines how ophthalmologists can select the most appropriate artificial cornea (keratoprosthesis or KPro) for patients with end-stage bilateral corneal blindness when conventional transplantation is no longer an option. The authors propose a decision-making algorithm that considers device design, patient anatomy, underlying diseases, and socioeconomic factors. Among available devices, Boston type 1 and type 2 keratoprostheses and the modified osteo-odonto-KPro remain the most widely used globally, with advances in biomaterials and prosthetic design significantly improving both anatomical retention rates and visual outcomes compared to earlier generations.
What the study looked like
This is a clinical review article rather than an original research study, meaning the authors synthesized existing evidence and clinical experience rather than enrolling new participants. The review focuses on patients with end-stage bilateral corneal blindness—individuals who have exhausted conventional treatment options like corneal transplantation due to severe ocular surface disease, repeated graft failures, or anatomical complications. The authors examined the design characteristics, surgical techniques, and postoperative care protocols for the most commonly used keratoprosthesis devices worldwide. They evaluated factors influencing device selection including ocular surface condition, eyelid anatomy, tear film quality, presence of systemic or autoimmune diseases, and patient-specific logistical and socioeconomic considerations. The review emphasizes a multidisciplinary approach involving preoperative counseling and long-term collaborative care.
Why researchers think this happened
The authors explain that keratoprosthesis technology has evolved substantially due to improvements in biomaterial science and prosthetic engineering, which have addressed earlier problems with device retention and infection. Different KPro designs suit different clinical scenarios: Boston type 1 works for patients with adequate blinking and tear film, type 2 serves those with severe dry eye or lid abnormalities, and osteo-odonto-KPro (which uses the patient’s own tooth and bone as a biological scaffold) provides exceptional retention in the most compromised eyes. The review’s decision-making framework emerged from recognizing that no single device fits all patients—successful outcomes depend on matching device characteristics to individual patient anatomy, disease processes, and ability to comply with intensive postoperative care. The multidisciplinary emphasis reflects understanding that these complex cases require coordinated input from cornea specialists, glaucoma experts, retina specialists, and sometimes rheumatologists for autoimmune conditions.
How to read this carefully
As a review article rather than original research, this work synthesizes existing evidence but does not provide new clinical trial data or specific success rates from a controlled study. The proposed decision algorithm represents expert opinion based on current literature and clinical experience, not a validated protocol tested in a randomized trial. Keratoprosthesis remains a “last resort” intervention for the most severe cases, meaning these patients often have multiple complicating factors that make outcomes inherently variable and difficult to predict. The review acknowledges that success depends heavily on patient selection, surgical expertise, and rigorous long-term follow-up—factors that vary considerably across medical centers and healthcare systems. Readers should recognize that even with optimal device selection, these procedures carry risks including infection, glaucoma progression, and device failure requiring revision surgery.
What this means for everyday life
For individuals facing end-stage corneal blindness after failed transplants or severe ocular surface disease, this review suggests that artificial cornea options have improved meaningfully and that personalized device selection matters for outcomes. If you or a loved one is confronting this situation, the research indicates it’s worth seeking care from centers with multidisciplinary teams experienced in keratoprosthesis surgery, as the decision involves weighing numerous anatomical, medical, and practical factors. The emphasis on preoperative counseling suggests patients should expect thorough discussions about which device suits their specific eye condition, overall health, and ability to maintain intensive postoperative care schedules. Given the complexity and socioeconomic considerations mentioned, patients might also consider discussing logistical challenges—such as travel for follow-up appointments and medication costs—with their care team before proceeding. While keratoprosthesis won’t suit everyone and requires realistic expectations, understanding that device selection can be tailored to individual circumstances may help patients feel more informed when navigating these difficult decisions.